Evaluation and Comparison of Characteristics and Outcomes Among Frontline Multiple Myeloma (FLMM) Patients with and without Stem Cell Transplant Treatment

被引：0
|
作者：
Chari, Ajai [1 ]
Mehra, Maneesha [2 ]
Slavcev, Mary [2 ]
Lam, Annette [2 ]
Potluri, Ravi [3 ]
Kaufman, Jonathan L. [4 ]
机构：
[1] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA
[2] Janssen Global Serv LLC, Raritan, NJ USA
[3] SmartAnalyst Inc, New York, NY USA
[4] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-113176
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4738
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Duration of frontline therapy and impact on clinical outcomes in newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant
    Ailawadhi, Sikander
    Ogbonnaya, Augustina
    Murty, Sharanya
    Cherepanov, Dasha
    Schroader, Bridgette Kanz
    Romanus, Dorothy
    Farrelly, Eileen
    Chari, Ajai
    CANCER MEDICINE, 2023, 12 (03): : 3145 - 3159
  • [2] Frontline treatment in multiple myeloma patients not eligible for stem-cell transplantation
    Facon, Thierry
    Darre, Stephane
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (04) : 737 - 746
  • [3] Characteristics, Time Trend and Outcomes of Patients Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
    Ailawadhi, Sikander
    Patel, Raj
    Meghji, Zahara
    Cochuyt, Jordan
    Hodge, David
    Vivek, Roy
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S138 - S139
  • [4] Economic Burden of Stem Cell Transplant Among Patients with Multiple Myeloma
    Ailawadhi, Sikander
    Panjabi, Sumeet
    Princic, Nicole
    Fowler, Rob
    Tran, Oth
    Gatta, Francesca
    Medhekar, Rohan
    BLOOD, 2017, 130
  • [5] Healthcare costs among multiple myeloma (MM) patients (Pts) without stem cell transplant (SCT).
    Panjabi, Sumeet
    Hagiwara, May
    Sharma, Arati
    Chen, Yaozhu J.
    Delea, Thomas E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Adoption of triplet therapy and clinical outcomes in routine practice among newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant in the USA
    Hari, Parameswaran
    Blazer, Marlo
    Raju, Aditya
    Farrelly, Eileen
    Labotka, Richard
    Skacel, Tomas
    Romanus, Dorothy
    EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (01) : 71 - 79
  • [7] HEALTHCARE COSTS AMONG MULTIPLE MYELOMA (MM) PATIENTS (PTS) WITHOUT STEM CELL TRANSPLANT (SCT)
    Panjabi, S.
    Hagiwara, M.
    Sharma, A.
    Delea, T. E.
    VALUE IN HEALTH, 2016, 19 (07) : A725 - A725
  • [8] Outcomes of Allogeneic Stem Cell Transplant for Multiple Myeloma
    Schmidt, Walker M.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Kumar, Shaji K.
    Dispenzieri, Angela
    Dingli, David
    Cook, Joselle
    Lacy, Martha Q.
    Kapoor, Prashant
    Leung, Nelson
    Muchtar, Eli
    Warsame, Rahma M.
    Kourelis, Taxiarchis
    Binder, Moritz
    Gonsalves, Wilson I.
    Gertz, Morie A.
    BLOOD, 2022, 140 : 7182 - 7184
  • [9] Outcomes after Autologous Stem Cell Transplant in Patients with Relapsed Multiple Myeloma
    Lemieux, Christopher
    Craig, Juliana
    Iberri, David
    Arai, Sally
    Johnston, Laura J.
    Lowsky, Robert
    Muffly, Lori S.
    Shiraz, Parveen
    Liedtke, Michaela
    Rezvani, Andrew R.
    Frank, Matthew J.
    Weng, Wen-Kai
    Meyer, Everett H.
    Shizuru, Judith A.
    Negrin, Robert S.
    Miklos, David B.
    Sidana, Surbhi
    BLOOD, 2020, 136
  • [10] Bortezomib Induction and Consolidation in Patients with Multiple Myeloma Who Received Frontline Autologous Stem Cell Transplant
    Tan, Sarah Ai Ting
    Shih, Steven
    Olasope, Scarlett
    Jackson, Sharon R.
    Poplar, Sarah
    Chan, Henry
    BLOOD, 2020, 136
12345